Tumor blood vessel signals turn cancer into a lethal disease resistant to chemotherapy

March 21, 2014

(Medical Xpress)—Blood vessels have been thought to be important to cancer because of the nutritious oxygen they provide to growing tumors. But now, researchers at Weill Cornell Medical College have discovered that the cells that line the blood vessels of tumors play a much more decisive role: By producing proteins that nurture cancer, the vessels have the ability to turn a slow-growing malignancy into an aggressive disease that can spread and resist treatment.

Their finding, in the March 17 issue of Cancer Cell , challenges what was believed to be a fundamental dogma in cancer. It suggests that it is not simply the number of genetic mutations that occur in cancer cells that determines the aggressiveness of the disease. Rather, lethality occurs when the cancer hijacks the reparative function of , a critical step that ensures ' ability to spread and resist treatment.

The researchers also found the crucial nurturing molecules that cancer co-opts from tumor blood vessels to promote invasiveness and resistance to chemotherapy. They show in animal experiments that shutting down these previously unrecognized biological signals originating from makes cancer less aggressive and improves survival.

"The that line the vessels orchestrate a wide variety of biological processes—good and bad," says the study's senior investigator, Dr. Shahin Rafii, co-director of Weill Cornell's Ansary Stem Cell Institute and Tri-Institutional Stem Cell Initiative, and a professor of Genetic Medicine. Dr. Rafii also is the founder of Angiocrine Bioscience, a startup anchored at Weill Cornell that is investigating how endothelial cells might be used to heal damaged tissues and regenerate organs - as well as target tumors. "The understanding and control of blood vessel function and how this changes the malignant behaviors of is a transformative concept and will pave the way for designing innovative treatments that disrupt signals from the local environment housing the tumor cells- a strategy that has been unappreciated."

The scientists studied human B cell lymphoma cells in both laboratory experiments and in mice. They found that although the lymphoma cells harbor the same mutations, it is their interaction with and support from the tumor that surround the cancer that dictates the fate and features of the disease.

Specifically, when slow-growing tumor cells contact endothelial cells that express a protein known as Jagged 1 (Jag 1), "they become much more aggressive and resistant to chemotherapy," says the study's lead investigator, Dr. Zhongwei Cao, a research scientist in the Department of Genetic Medicine at Weill Cornell. "When Jagged 1 is not available from surrounding blood vessels, the lethal features of tumor cells are absent."

They further found that when Jag1 binds to and activates a receptor, Notch2, on tumor cells, the cancer becomes more tolerant of chemotherapy. "These tumor cells are sheltered from chemotherapy," Dr. Cao says.

The researchers, joined by colleagues at Stanford and Yale, also identified how interactions between the tumor cells and the blood vessels confer these tumor cells with their aggressive and lethal features. "We think signals from these abnormally stimulated tumor endothelial cells modulate the malignant features of lymphoma cells. This is a reversible process dictated by the location of the tumor cells rather than their genetics," says Dr. Joseph Scandura, an assistant professor of medicine at Weill Cornell. "This is a critical finding because it suggests that targeting the endothelial cells with agents that disrupt their specific pro-tumorigenic signals can transform aggressive cancers into slow-growing cancers that are more sensitive tochemotherapy."

The researchers found, for example, that blocking the Notch2 receptor in lymphoma cells or Jag1 on blood vessels made the lymphoma cells significantly more vulnerable to chemotherapy. Even though the experiment was conducted using , "we expect this finding to be applicable to other cancers, as well," says Dr. Bi-Sen Ding, co- senior investigator of the study and an assistant professor of genetic medicine at Weill Cornell.

"This new approach to treatment would interfere with the nurturing proteins produced by tumor blood vessels. It is different from traditional anti-angiogenic therapy that aims to eradicate all blood vessels in the tumor and prevent them from bringing oxygen and nutrients to the cancer," says Dr. Ding, noting that conventional anti-angiogenic therapy can increase the aggressiveness of certain tumor cells by paradoxically enhancing the expansion of tumor blood vessels. "Simply blocking specific proteins produced by tumor blood vessels, such as Jag1, without altering oxygen and nutrient delivery will avoid this problem.

"Our approach could readily be translated to the clinical setting since we can target by delivering biological cruise missiles loaded with inhibitory agents for specific cancer-promoting proteins to block tumor growth and increase sensitivity to chemotherapy," Dr. Ding adds.

Finally, these studies suggest that screening for anti- drugs may be more effective if tumor cells are assayed in the context of signals derived from the subverted blood vessels.

Explore further: Study reveals mechanisms cancer cells use to establish metastatic brain tumors

More information: "Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance." Zhongwei Cao, Bi-Sen Ding, Peipei Guo, Sharrell B. Lee, Jason M. Butler, Stephanie C. Casey, Michael Simons, Wayne Tam, Dean W. Felsher, Koji Shido, Arash Rafii, Joseph M. Scandura, Shahin Rafii. Cancer Cell - 17 March 2014 (Vol. 25, Issue 3, pp. 350-365) DOI: 10.1016/j.ccr.2014.02.005

Related Stories

Study reveals mechanisms cancer cells use to establish metastatic brain tumors

February 27, 2014
New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the February 27 issue of Cell, the study found that ...

New type of cell communication regulates blood vessel formation and tumor growth

March 20, 2014
When tumours grow, new blood vessels are formed that deliver oxygen and nutrients to the tumour cells. A research group at Uppsala University has discovered a new type of cell communication that results in suppressed blood ...

New target for the fight against cancer as a result of excessive blood vessel formation

August 1, 2013
New blood vessel formation (angiogenesis) stimulates the growth of cancer and other diseases. Anti-angiogenic inhibitors slow down cancer growth by disrupting the blood supply to the tumor. To date, the success of these treatments ...

Nano drug crosses blood-brain tumor barrier, targets brain tumor cells and blood vessels

July 17, 2013
(Phys.org) —An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a recent study led ...

Study links cardiac hormone-related inflammatory pathway with tumor growth

June 28, 2013
(Medical Xpress)—A cardiac hormone signaling receptor abundantly expressed both in inflamed tissues and cancers appears to recruit stem cells that form the blood vessels needed to feed tumor growth, reports a new study ...

Anti-tumor activity of immune cells can be restored

December 10, 2013
The Leuven-based VIB researchers have revealed a mechanism that explains why the anti-tumor activity of specific immune cells called macrophages is suppressed during tumor growth. They have also demonstrated that blocking ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.